Aurobindo Pharma said it has received US health regulator8217;s nod to market 8216;Galantamine Tablets8217;,used in the treatment of Alzheimer disease,in the American market.
The Hyderabad-based firm has received approval from US Food and Drug Administration to market and manufacture Galantamine Tablets in strengths of 4mg,8mg and 12mg,Aurobindo Pharma said in a statement.
8220;The product has a market size of approximately USD 41 million for the twelve months ending September 2010,according to IMS and will be launched shortly,8221; the company said.
Galantamine Tablets is the generic version of Ortho McNeil Janssen Pharmaceutical,Inc8217;s Razadyne Tablets and falls under the neurological CNS therapeutic category.
The tablets are used for treatment of mild to moderate dementia of the Alzheimer8217;s type.
Shares of Aurobindo Pharma today closed at Rs 193.80 on the Bombay Stock Exchange,up 1.17 from its previous close.